Professional and Reliable IHC Raw Antibody Solutions for Colon Pathology
Colon pathology frequently requires differentiation between adenocarcinoma and other intestinal lesions. AREX provides high-quality IHC raw antibodies supporting detection of epithelial markers, proliferation and differentiation-related targets to optimize diagnostic and subtyping solutions.
Core Advantages:
High specificity and low background suited to the mucosal staining environment of intestinal tissue
Good sensitivity meeting needs across different lesion types
Excellent batch-to-batch consistency for large-scale OEM supply
AREX colon pathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.